Skip to main content

PRF Technologies Ltd.

corporate_fare Company Profile

PRF Technologies Ltd.

PRFX·NASDAQ·Life Sciences·CIK 0001801834

PRF Technologies is a specialty pharmaceutical company that reformulates existing therapeutics. The company uses a proprietary extended-release drug-delivery system designed to offer prolonged post-surgical pain relief without repeated dosing, aiming to reduce the need for opiates. In March 2025, PRF Technologies acquired the business operations related to DeepSolar, an AI-driven solar analytics technology. Within its Drug Development Business, PRF Technologies' strategy involves combining generic drugs with its extended-release drug-delivery system to create extended-release drug products. This approach leverages the FDA's 505(b)(2) regulatory pathway, which allows for new drug approval based partly on data developed by others, including published literature and data previously reviewed by the FDA. PRF-110, the company's initial product candidate, uses the local anesthetic ropivacaine and targets the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution applied directly into the surgical wound bed before closure to provide localized and extended post-operative pain relief. A 15-patient Phase 2 proof-of-concept clinical study in hernia repair showed PRF-110 provided significant pain reduction for up to 72 hours post-operatively. This contrasts with ropivacaine alone, which provides pain relief for only 2 to 6 hours according to its FDA-approved drug description. Surgeons in the PRF-110 Phase 2 trial reported easy integration into procedures without disrupting existing surgical techniques. Ropivacaine, the active drug in PRF-110, is a safe and well-characterized local analgesic, and other components in the PRF-110 formulation are classified as GRAS (Generally Regarded As Safe) by the FDA.

PRF Technologies Ltd. (NASDAQ:PRFX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 36 items for PRFX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-19, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for PRFX spans SCHEDULE 13D/A, 6-K, SCHEDULE 13D, 424B3.

Recent high-impact activity:

  • Activist S.H.N. Asks Tel Aviv Court to Force Board Vote at December 21 AGM
  • PRF Sets Dec 21 AGM: 5-to-1 Reverse Split, Share Increase, CEO Pay Votes
  • PRF Receives Nasdaq Delisting Determination, Requests Hearing to Stay Suspension
  • Nasdaq Moves to Delist PRF Technologies After Sub-$1 Bid; Hearing Request Stays Suspension
  • PRF Adds Risk Warnings as Activist S.H.N. Presses Tel Aviv Court for Special Meeting

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$17K
Net Income
-$5.02M
Diluted EPS
-$7.47
Op. Cash Flow
-$3.96M
Free Cash Flow
-$3.96M
Gross Profit
-$53K
Operating Income
-$5.12M
Cash & Equivalents
$3.13M
Debt / Equity
0.00×
Net Margin
-295.41×
Shares Outstanding
830.61K sh
Source: 20-F · filed 2026-03-26 · accession 0001178913-26-001782

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 12,815 shares in PRFX as of the October 30, 2026 settlement, a 35.9% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 35.2% of PRFX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)12,815 shares as of October 30, 2026
Change vs prior period▼ 35.9%
Days to cover1.00 at avg daily volume of 32,611
Daily short volume (FINRA facilities)35.2% of 32,772 shares on November 20, 2026
5-day average short volume31.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for PRFX, detected from its recent SEC filings · based on capital-structure filings through 2026-06-29.

1 shelf registration

Finalizes $15M Equity Line · Significant Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Insider Transactions

PRFX files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with P →
$0.491 +3.19% today
52-week range · as of 2026-11-19 $0.491 – $7.95
Market cap
$1.66M
Volume
69.9K (0.4× avg)
3-mo avg 197.7K
Live data · 2026-11-21 15:02 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed PRFX - Latest Insights

PRFX
Nov 19, 2026, 2:08 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.6076
Real-time Price: $0.491 info
Change: -$0.1166 (-19%) info
Market Cap: $1.665M info
PRFX
Nov 13, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.7834
Real-time Price: $0.491 info
Change: -$0.2924 (-37%) info
Market Cap: $1.665M info
PRFX
Nov 12, 2026, 4:31 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.7354
Real-time Price: $0.491 info
Change: -$0.2444 (-33%) info
Market Cap: $1.665M info
PRFX
Nov 12, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.786
Real-time Price: $0.491 info
Change: -$0.295 (-38%) info
Market Cap: $1.665M info
PRFX
Nov 05, 2026, 4:15 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7588
Real-time Price: $0.491 info
Change: -$0.2678 (-35%) info
Market Cap: $1.665M info
PRFX
Nov 03, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7705
Real-time Price: $0.491 info
Change: -$0.2795 (-36%) info
Market Cap: $1.665M info
PRFX
Nov 03, 2026, 4:01 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.711
Real-time Price: $0.491 info
Change: -$0.220 (-31%) info
Market Cap: $1.665M info
PRFX
Sep 24, 2026, 4:15 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $1.07
Real-time Price: $0.491 info
Change: -$0.579 (-54%) info
Market Cap: $1.665M info
PRFX
Sep 09, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.945
Real-time Price: $0.491 info
Change: -$0.454 (-48%) info
Market Cap: $1.665M info
PRFX
Sep 03, 2026, 8:39 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.00
Real-time Price: $0.491 info
Change: -$0.509 (-51%) info
Market Cap: $1.665M info
PRFX
Sep 03, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.00
Real-time Price: $0.491 info
Change: -$0.511 (-51%) info
Market Cap: $1.665M info
PRFX
Jul 27, 2026, 8:47 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.11
Real-time Price: $0.491 info
Change: -$0.6155 (-56%) info
Market Cap: $1.665M info
PRFX
Jul 08, 2026, 8:45 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.31
Real-time Price: $0.491 info
Change: -$0.819 (-63%) info
Market Cap: $1.665M info
PRFX
Jul 08, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.43
Real-time Price: $0.491 info
Change: -$0.939 (-66%) info
Market Cap: $1.665M info
PRFX
Jun 29, 2026, 5:00 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $1.41
Real-time Price: $0.491 info
Change: -$0.919 (-65%) info
Market Cap: $1.665M info
PRFX
Jun 25, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.58
Real-time Price: $0.491 info
Change: -$1.09 (-69%) info
Market Cap: $1.665M info
PRFX
Jun 25, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.49
Real-time Price: $0.491 info
Change: -$0.999 (-67%) info
Market Cap: $1.665M info
PRFX
Jun 22, 2026, 4:15 PM EDT
Filing Type: F-1
Importance Score:
9
Price at Filing: $1.61
Real-time Price: $0.491 info
Change: -$1.12 (-70%) info
Market Cap: $1.665M info
PRFX
Jun 18, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.64
Real-time Price: $0.491 info
Change: -$1.14 (-70%) info
Market Cap: $1.665M info
PRFX
May 28, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.33
Real-time Price: $0.491 info
Change: -$0.839 (-63%) info
Market Cap: $1.665M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets